Found 12 matching trials
Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma PHASE1 Patients have a type of cancer called sarcoma. Because there is no standard...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine PHASE1 This phase I trial studies the safety and the ability to expand laboratory-...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors PHASE1 This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma PHASE1 This is a Phase I study to evaluate the safety profile of a type of immune ...
Show More Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Learn More & Join Trial
CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM PHASE1 This study is for patients that have a type of brain cancer called glioblas...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) PHASE2 RATIONALE: Drugs used in chemotherapy, such as paclitaxel, cyclophosphamide...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida
Learn More & Join Trial
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) PHASE1 Phase I/II study of adoptive immunotherapy for advanced MUC1\* positive bre...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Stage IV Breast Cancer PHASE1 This phase I/II trial is studying the side effects of escalating doses of a...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma PHASE1 This phase I trial studies the side effects and best dose of memory-enriche...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors PHASE1 This is a Phase 1 study of central nervous system (CNS) locoregional adopti...
Show More Status
Active Not Recruiting
Location
Seattle Children's Hospital
Learn More & Join Trial